Sovaldi And The Case Against Incentives
This article was originally published in RPM Report
Executive Summary
The House Energy &Commerce Committee’s “21st Century Cures” initiative has provided a very friendly forum for the biopharma industry to advance ideas to improve the public policy climate for innovation. However, not everyone agrees that more incentives mean more innovation. During a June 11 hearing, Express Scripts Chief Medical Officer Steven Miller argued that enough is enough.